AVEKTRUS

Welcome to the Brand page for “AVEKTRUS”, which is offered here for (based on intent to use) pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kallikrein or factor xiia mediated diseases or disorders; pharmaceutical preparations for containing sebetralstat; pharmaceutical preparations for containing feniralstat(based on 44(d) priority application) pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kallikrein or factor xiia mediated diseases or disorders; pharmaceutical preparations for containing sebetralstat; pharmaceutical preparations for containing feniralstat;.

Its status is currently believed to be active. Its class is unavailable. “AVEKTRUS” is believed to be currently owned by “Kalvista Pharmaceuticals Limited”.